News

Medical Device Network on MSN2d
Abbott’s studies show CGM technology linked to lower heart hospitalisation risk
Abbott's REFLECT real-world retrospective studies indicate that FreeStyle Libre continuous glucose monitoring (CGM) ...
Abbott Laboratories (ABT)’s Libre Linked to Fewer Heart Hospitalizations in Diabetes
Abbott Laboratories (NYSE:ABT) recently shared findings from its REFLECT real-world studies, revealing that the use of its FreeStyle Libre® continuous glucose monitoring (CGM) system is linked to a ...
Drug Delivery Business3d
Study links Abbott CGM use to lower risk of hospitalizations due to heart complications
Abbott today announced results from real-world studies demonstrating benefits with its FreeStyle Libre CGM technology.
Mena FN19d
Abbott Integrates Libre's Data With Epic's Electronic Health Record System, Providing Healthcare Professionals Seamless Glucose Monitoring Information
April 29, 2025 /PRNewswire/ -- Abbott (NYSE: ABT ), the global leader in continuous glucose monitoring ... information, visit * Study was performed with the outside US version of the FreeStyle ...